Know Labs Past Earnings Performance

Past criteria checks 0/6

Know Labs's earnings have been declining at an average annual rate of -9.3%, while the Medical Equipment industry saw earnings growing at 11.7% annually. Revenues have been declining at an average rate of 15.2% per year.

Key information

-9.3%

Earnings growth rate

14.7%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate-15.2%
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Know Labs makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSEAM:KNW Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 240-1796
30 Jun 240-1687
31 Mar 240-2177
31 Dec 230-2067
30 Sep 230-2068
30 Jun 230-2398
31 Mar 230-17108
31 Dec 220-1996
30 Sep 224-20125
30 Jun 224-2294
31 Mar 224-2684
31 Dec 214-2584
30 Sep 210-2564
30 Jun 210-2274
31 Mar 210-1863
31 Dec 200-1673
30 Sep 200-1452
30 Jun 200-1252
31 Mar 201-1252
31 Dec 191-1042
30 Sep 192-841
30 Jun 192-531
31 Mar 193-431
31 Dec 184-331
30 Sep 184-331
30 Jun 185-330
31 Mar 185-230
31 Dec 175-220
30 Sep 175-430
30 Jun 175-440
31 Mar 176-340
31 Dec 166-240
30 Sep 166-230
30 Jun 166-330
31 Mar 166-430
31 Dec 156-130
30 Sep 156-330
30 Jun 157030
31 Mar 157130
31 Dec 148-330
30 Sep 148-131
30 Jun 148-231
30 Mar 148-641

Quality Earnings: KNW is currently unprofitable.

Growing Profit Margin: KNW is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: KNW is unprofitable, and losses have increased over the past 5 years at a rate of 9.3% per year.

Accelerating Growth: Unable to compare KNW's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: KNW is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (15%).


Return on Equity

High ROE: KNW's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/12 08:51
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Know Labs, Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bruce JacksonBenchmark Company
Marco RodriguezStonegate Capital Markets, Inc.